Literature DB >> 18809337

The distribution of interleukin-19 in healthy and neoplastic tissue.

Chung-Hsi Hsing1, Hsing-Hui Li, Yu-Hsiang Hsu, Chung-Liang Ho, Shih-Sung Chuang, Kuo-Mao Lan, Ming-Shi Chang.   

Abstract

The influence of interleukin (IL)-19, a recently discovered cytokine in the IL-10 family, on tissue is still unclear. Our aim was to determine the distribution of IL-19 expression and to delineate the cell types that express IL-19 in healthy and neoplastic tissue, because this information will significantly facilitate the exploration of its pathophysiological functions. We used tissue microarray technology and an immunohistochemical survey with an anti-IL-19 monoclonal antibody to examine the expression of IL-19 in 28 healthy and 15 neoplastic tissues. IL-19 protein was positively stained in 15 healthy tissue types and three major cell types: epithelial cells, endothelial cells, and macrophages. We also found that several types of tumor cells were positively stained for IL-19, especially in squamous cell carcinoma (SCC) of the skin, tongue, esophagus, and lung. SCC of the oral cavity expressed IL-19 mRNA and its receptors. In two cell lines derived from SCC of oral cavity tumor tissue, IL-19 specifically activated an intracellular signal and induced proliferation of the cells, which indicated that IL-19 may act in an autocrine manner in SCC tumors. This study provides important references for further investigation of the biological functions and clinical implications of IL-19 in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809337     DOI: 10.1016/j.cyto.2008.06.007

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

1.  Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.

Authors:  G Fonseca-Camarillo; J Furuzawa-Carballeda; J Granados; J K Yamamoto-Furusho
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

2.  The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells.

Authors:  Surbhi Jain; Khatuna Gabunia; Sheri E Kelemen; Tracee S Panetti; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-21       Impact factor: 8.311

3.  Interleukin-19 impairment in active Crohn's disease patients.

Authors:  Elisabet Cantó; Esther Garcia Planella; Carlos Zamora-Atenza; Juan Camilo Nieto; Jordi Gordillo; Ma Angels Ortiz; Isidoro Metón; Elena Serrano; Esteban Vegas; Orlando García-Bosch; Cándido Juárez; Sílvia Vidal
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

4.  Interleukin-19 acts as a negative autocrine regulator of activated microglia.

Authors:  Hiroshi Horiuchi; Bijay Parajuli; Yue Wang; Yasu-Taka Azuma; Tetsuya Mizuno; Hideyuki Takeuchi; Akio Suzumura
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

5.  Blocking IL-19 Signaling Ameliorates Allergen-Induced Airway Inflammation.

Authors:  Yun-Han Weng; Wei-Yu Chen; Yen-Lin Lin; Jiu-Yao Wang; Ming-Shi Chang
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

6.  Anti-inflammatory effects of interleukin-19 in vascular disease.

Authors:  Ross N England; Michael V Autieri
Journal:  Int J Inflam       Date:  2012-07-15

Review 7.  Interleukin-19 in breast cancer.

Authors:  Ying-Yin Chen; Chien-Feng Li; Ching-Hua Yeh; Ming-Shi Chang; Chung-Hsi Hsing
Journal:  Clin Dev Immunol       Date:  2013-04-22

8.  Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression.

Authors:  Chung-Hsi Hsing; Franky Antonius Kwok; Hung-Chi Cheng; Chien-Feng Li; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

Review 9.  Cytokine inhibition in the treatment of COPD.

Authors:  Gaetano Caramori; Ian M Adcock; Antonino Di Stefano; Kian Fan Chung
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-04-28

10.  Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma.

Authors:  Yi-Shu Chiu; Chung-Hsi Hsing; Chien-Feng Li; Chon-Yee Lee; Yu-Hsiang Hsu; Ming-Shi Chang
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.